NEW YORK, Dec. 30, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of PACS Group, Inc. (NYSE: PACS).Shareholders who purchased shares of PACS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/pacs-group-inc-loss-submission-form/?id=118943&from=4CLASS PERIOD: This lawsuit is on beha ...

Lawsuit Details - A securities class action lawsuit has been filed against PACS Group, Inc in the United States District Court for the Southern District of New York [1] - The lawsuit is on behalf of investors who purchased or acquired PACS common stock pursuant to the Registration Statement issued in connection with PACS' April 11, 2024 IPO and/or securities between April 11, 2024 and November 5, 2024 [1] - The lead plaintiff deadline is January 13, 2025 [1] Allegations - Defendants made materially false and/or misleading statements and failed to disclose material adverse facts about PACS' business, operations, and prospects [9] - PACS engaged in a scheme to submit false Medicare claims which drove more than 100% of PACS' operating and net income from 2020 – 2023 [9] - The company engaged in a scheme to bill thousands of unnecessary respiratory and sensory integration therapies to Medicare [9] - PACS engaged in a scheme to falsify documentation related to licensure and staffing [9] - Defendants' positive statements about the company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis [9] Lead Plaintiff Process - PACS investors may seek to be appointed as a lead plaintiff representative of the class through Kessler Topaz Meltzer & Check, LLP or other counsel by January 13, 2025 [11] - The lead plaintiff is usually the investor or small group of investors who have the largest financial interest and who are also adequate and typical of the proposed class of investors [11] - The lead plaintiff selects counsel to represent the lead plaintiff and the class [11] - The ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff [11]

RADNOR, Pa., Dec. 27, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against PACS Group, Inc. ("PACS") (NYSE: PACS). The lawsuit is brought on behalf of investors who purchased or otherwise acquired PACS: 1) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement") issued in connection with PACS' April 11, 2024 initial public o ...

Core Viewpoint - A class action securities lawsuit has been filed against PACS Group, Inc. alleging securities fraud that adversely affected investors who purchased the company's stock during its initial public offering and subsequent period [2][4]. Group 1: Lawsuit Details - The lawsuit seeks to recover losses for investors who acquired PACS Group's common stock from April 11, 2024, to November 5, 2024 [2]. - Allegations include that the company engaged in a scheme to submit false Medicare claims, which accounted for over 100% of PACS' operating and net income from 2020 to 2023 [2]. - Additional claims involve billing for unnecessary therapies to Medicare and falsifying documentation related to licensure and staffing, leading to materially misleading statements about the company's business and prospects [2]. Group 2: Investor Information - Investors affected by the alleged fraud have until January 13, 2025, to request appointment as lead plaintiff in the lawsuit [7]. - Participation in the lawsuit does not require serving as a lead plaintiff to share in any potential recovery [7].

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In PACS Group To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in PACS Group between (a) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) issued in connection with the Company’s April 11, 2024 initial public offering (“IPO” or the “Offering”); and/or (b) all pe ...

Core Viewpoint - A lawsuit has been filed against PACS Group, Inc. and its senior executives for potential violations of federal securities laws, alleging that the company misrepresented its financial health and turnaround strategy to shareholders [1][3]. Group 1: Lawsuit Details - The lawsuit claims that PACS, a major operator of skilled nursing facilities in the U.S., falsely represented its turnaround strategy as successful while actually relying on illicit access to Medicare benefits for thousands of patients [2][3]. - Investors have until January 13, 2025, to request to lead the case, which is pending in the U.S. District Court for the Southern District of New York [3]. Group 2: Impact of Hindenburg Research Report - On November 4, 2024, Hindenburg Research published a report alleging that PACS abused COVID-era waivers to access Medicare benefits, which they claim accounted for over 100% of PACS's operating and net income from 2020 to 2023 [4]. - Following the report, PACS's stock price dropped significantly, falling 27.8% from $42.94 to $31.01 per share on November 4, 2024, and then another 38.8% from $29.54 to $18.09 per share on November 6, 2024 [4]. Group 3: Company Response - On November 6, 2024, PACS announced the postponement of its Q3 earnings and disclosed that it had received civil investigative demands from the federal government regarding its reimbursement and referral practices [11].

Investors interested in stocks from the Medical Services sector have probably already heard of PACS Group, Inc. (PACS) and HealthEquity (HQY) . But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look.We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The Zacks Rank favors stocks with strong earnings estimate revision tren ...

NEW YORK, Dec. 23, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of PACS Group, Inc. (NYSE: PACS).Shareholders who purchased shares of PACS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/pacs-group-inc-loss-submission-form/?id=117769&from=4 CLASS PERIOD: This lawsuit is on  be ...

RADNOR, Pa., Dec. 22, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against PACS Group, Inc. (“PACS”) (NYSE: PACS). The lawsuit is brought on behalf of investors who purchased or otherwise acquired PACS: 1) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registrati ...

NEW YORK, Dec. 22, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against PACS Group, Inc. (NYSE: PACS) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in PACS, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases-investigations/pacs-group-inc. Investors have until January 13, 2025, to ask the Court to be appointed to lead t ...